SC
ALXN

Sculptor Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Sculptor Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-580,776
Closed -$107M – 1183
2021
Q2 		$107M Sell
580,776
-1,441,598
-71% -$247M 0.92% 34
2021
Q1 		$309M Buy
2,022,374
+1,688,169
+505% +$261M 2.74% 6
2020
Q4 		$52.2M Buy
+334,205
New +$42.9M 0.47% 50
2015
Q1 		– Sell
-6,772
Closed -$1.25M – 875
2014
Q4 		$1.25M Sell
6,772
-2,200
-25% -$408K 0.01% 610
2014
Q3 		$1.49M Sell
8,972
-900
-9% -$148K 0.01% 637
2014
Q2 		$1.54M Sell
9,872
-3,500
-26% -$553K 0.01% 627
2014
Q1 		$2.03M Buy
+13,372
New +$2.13M 0.01% 603

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return